Menu

Home / Guides / Tirzepatide half-life

How long it lasts. What it means for you.

Tirzepatide half-life: how long it lasts in your body

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated

Tirzepatide’s half-life is about 5 days on Mounjaro’s label and 5 to 6 days on Zepbound’s (both revised August 2026): one weekly shot covers the week, and levels reach a steady state after 4 weeks. By simple halving, about 3% is left 25 to 30 days after the last dose. Compounded tirzepatide isn’t FDA-approved and wasn’t studied.

  • Half-life: about 5 days, or 5 to 6 days on Zepbound’s label
  • Steady level: after 4 weeks of once-weekly doses
  • Missed dose: the labels’ window is 4 days (96 hours)

How long does tirzepatide last? The short answer

Half-life
About 5 days on Mounjaro’s label; 5 to 6 days on Zepbound’s
Steady level
After 4 weeks of once-weekly doses, both labels say
After the last dose
About 3% left after 5 half-lives: roughly 25 to 30 days, by simple halving
Missed a dose
Labels: up to 4 days (96 hours) late; doses at least 3 days apart
Before surgery
Tell your care team you take it; don’t stop on your own

A question about your dose schedule? Call or text (949) 818-8000. Real people answer 24/7.

Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • About 5 days. That’s tirzepatide’s half-life on Mounjaro’s label; Zepbound’s says 5 to 6 days (both revised August 2026). It’s why one shot a week is enough.
  • Steady after 4 weeks. Each weekly shot adds to what’s left of the last, and levels plateau after 4 weeks of once-weekly doses, both labels say.
  • Weeks to clear. The labels give no clearance time. By simple halving, about 3% is left after 5 half-lives: roughly 25 to 30 days after the last dose.
  • Missed a dose? Both labels allow up to 4 days (96 hours) and want doses at least 3 days (72 hours) apart. Your prescriber’s instructions come first.
  • Surgery or the pill? Tell your care team you take it. On birth control pills, the labels advise a non-oral or barrier backup for 4 weeks after starting and after each dose increase.
  • At NexLife, compounded tirzepatide, which isn’t FDA-approved, is $115 a month on the 12-month plan, at every dose. Schedule questions? Real people answer 24/7.

The labels

What is tirzepatide’s half-life, according to the labels?

Tirzepatide’s half-life is about 5 days: that’s the figure in Mounjaro’s label and in both labels’ overdose sections, while Zepbound’s pharmacology section says 5 to 6 days (both revised August 2026).

From the Zepbound and Mounjaro prescribing information (both revised August 2026), read November 18, 2026. These figures come from studies of FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.
ZepboundMounjaroCompounded tirzepatide
Made byEli LillyEli LillyA state-licensed pharmacy, for one patient’s prescription
FDA-approved forWeight reduction and keeping it off in adults with obesity, or overweight with a weight-related condition; moderate to severe sleep apnea in adults with obesityType 2 diabetes, from age 10; lowering heart attack, stroke and heart-death risk in high-risk adults with itNot FDA-approved
How you take itA shot once a week: 2.5 mg to start, up to 15 mgA shot once a week: 2.5 mg to start, up to 15 mg (10 mg in children)Your prescription sets the dose and form
Half-lifetime for blood levels to halveAbout 5 to 6 days (section 12.3); about 5 days in its overdose sectionAbout 5 daysNo FDA label; not studied
Steady levelAfter 4 weeks of once-weekly dosesAfter 4 weeks of once-weekly dosesNot studied
Peak after a shotA median of 24 hours (range 8 to 72 hours)8 to 72 hoursNot studied
Reaches the bloodbioavailability80% of a dose80% of a doseNot studied
A missed doseTaken within 4 days (96 hours); later, skipped, with the next dose on the usual dayThe same 4-day ruleYour prescription and your prescriber decide

Swipe the table sideways to see every column.

From the Zepbound and Mounjaro prescribing information (both revised August 2026), read November 18, 2026. These figures come from studies of FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.

Why two numbers? Zepbound’s pharmacology section gives 5 to 6 days in people with overweight or obesity, with or without sleep apnea. Mounjaro’s label, for type 2 diabetes, gives about 5 days, and both labels use about 5 days in their overdose sections. Either way, it’s roughly 5 days. The two brands, compared: Mounjaro vs. Zepbound.

Why it lasts. Tirzepatide carries a fatty acid that binds albumin, a protein in your blood, and that prolongs its half-life, Zepbound’s label says; 99% of it is bound to albumin.

Your own clock can differ. In a 2022 study in Clinical Pharmacokinetics, one 5 mg dose in 32 adults gave an average half-life of 124 hours, about 5 days, in the 13 with normal liver function; individual values ran from 101 to 158 hours. It was similar in people with liver impairment. Compounded tirzepatide wasn’t studied.

Your situation

Why does tirzepatide’s half-life matter? Start with your situation

Tirzepatide’s half-life of about 5 days shapes what happens when you miss a dose, plan surgery or a pregnancy, take birth control pills or switch medicines. Your prescriber decides any change to your doses.

  • You missed a dose

    Both labels allow up to 4 days (96 hours) to take it, and want two doses at least 3 days (72 hours) apart. Your prescription and your prescriber’s instructions come first: the 4-day rule.

  • You have surgery coming up

    Tell everyone treating you that you take tirzepatide, and when you took your last dose. Whether to hold one is your care team’s call: what the labels and guidance say.

  • You take birth control pills

    The labels advise switching to a non-oral method, or adding a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase.

  • You’re planning a pregnancy

    Zepbound’s label sets no stop time before you try; it advises stopping once a pregnancy is recognized. Tell your prescriber your plans early: pregnancy and birth control.

  • You’re switching from semaglutide

    Semaglutide’s half-life is about 1 week, per the Wegovy label (revised June 2026), and the labels advise against combining the two. Your prescriber sets the day of your first tirzepatide dose.

  • You take compounded tirzepatide

    Zepbound and Mounjaro are the FDA-approved brand-name tirzepatide medicines. Compounded tirzepatide is made by a pharmacy, isn’t FDA-approved and isn’t reviewed by the FDA for safety, effectiveness or quality, so the labels’ numbers apply to the approved products. Your prescription sets your schedule.

From the Zepbound and Mounjaro prescribing information (revised August 2026) and the Wegovy prescribing information (revised June 2026). Your prescriber decides any change to your doses.

After the last dose

How long does tirzepatide stay in your system after the last dose?

Tirzepatide stays in your system for several weeks after the last dose. The labels give no clearance time, but at a half-life of 5 to 6 days, simple halving leaves about 3% after 5 half-lives: roughly 25 to 30 days.

An estimate, not a measurement: what’s left of tirzepatide after the last dose if it halves every 5 days (Mounjaro’s label) or every 6 days (the top of Zepbound’s 5 to 6 days), both labels revised August 2026. Your own timing can differ, and compounded tirzepatide wasn’t studied.
Half-lives since the last doseShare left, aboutAt 5 days eachAt 6 days each
1 half-life50%Day 5Day 6
2 half-lives25%Day 10Day 12
3 half-lives12.5%Day 15Day 18
4 half-lives6%Day 20Day 24
5 half-lives3%Day 25Day 30
6 half-lives1.6%Day 30Day 36
7 half-lives0.8%Day 35Day 42

Swipe the table sideways to see every column.

An estimate, not a measurement: what’s left of tirzepatide after the last dose if it halves every 5 days (Mounjaro’s label) or every 6 days (the top of Zepbound’s 5 to 6 days), both labels revised August 2026. Your own timing can differ, and compounded tirzepatide wasn’t studied.

Where “5 half-lives” comes from. The tirzepatide labels stop at the half-life. Wegovy’s label goes further for semaglutide: with a half-life of about 1 week, it says semaglutide “will be present in the circulation for about 5 to 7 weeks” after a last 2.4 mg or 7.2 mg shot (revised June 2026). That’s 5 to 7 half-lives; for tirzepatide, the same count gives about 25 to 42 days.

Blood levels aren’t the whole story. The half-life describes tirzepatide in your blood. Its stomach-slowing effect runs on a different clock: it’s largest after the first dose and eases over time, Zepbound’s label says.

Stopping or pausing? Talk with your prescriber first, and ask how you’d restart: restarting tirzepatide after a break. Side effects that won’t settle? See tirzepatide side effects.

In their words

Why does one tirzepatide shot last a whole week?

One tirzepatide shot lasts a week because the molecule is built to stay in your blood. Zepbound’s label explains how:

“It contains a C20 fatty diacid that enables albumin binding and prolongs the half-life.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, section 12.1, revised August 2026

Steady level

When does tirzepatide reach a steady level in your body?

Tirzepatide reaches a steady level after 4 weeks of once-weekly doses, both labels say. Each weekly shot lands on what’s left of the last one, so levels climb for about 4 weeks, then hold.

“Steady-state plasma tirzepatide concentrations were achieved following 4 weeks of once weekly administration.”

Eli Lilly and Company, Zepbound prescribing information, section 12.3, revised August 2026; Mounjaro’s label says the same
From the Zepbound prescribing information (sections 2, 12.2 and 12.3) and Mounjaro’s (section 12.3), both revised August 2026, read November 18, 2026. The last column’s percentages are simple-halving math from the labels’ half-life, not label figures. Compounded tirzepatide wasn’t studied.
WhenWhat the labels sayWhat it means
The first shotday 1Levels peak a median of 24 hours after a shot (range 8 to 72 hours); 80% of the dose reaches the bloodSlower stomach emptying is largest now and eases over time, the label says
Weeks 1 to 42.5 mg once a week, the starting doseAbout 38% to 45% of each dose is still there when the next is due, so levels build
Week 4Steady state is reachedOn the same dose, the weekly rise and fall now repeats
Week 5 onThe dose may rise 2.5 mg at a time, after at least 4 weeks on the current doseEach step lasts at least 4 weeks, the span the labels give for a steady level

Swipe the table sideways to see every column.

From the Zepbound prescribing information (sections 2, 12.2 and 12.3) and Mounjaro’s (section 12.3), both revised August 2026, read November 18, 2026. The last column’s percentages are simple-halving math from the labels’ half-life, not label figures. Compounded tirzepatide wasn’t studied.

The math behind the build-up. At a half-life of 5 to 6 days, about 38% to 45% of a dose is still there when the next weekly one is due (½ raised to the power of 7 days ÷ the half-life). Each shot adds to what’s left until levels plateau, which the labels put at 4 weeks.

Moving your dose day. The labels allow a new weekly day as long as two doses are at least 3 days (72 hours) apart. Ask your prescriber before you change it.

More on the first months: the tirzepatide timeline, month by month and how to inject tirzepatide from a vial.

Missed doses

What if you miss a tirzepatide dose? The 4-day rule

Both tirzepatide labels give the same missed-dose window: a missed dose is taken as soon as possible within 4 days (96 hours); after that, they say it’s skipped and the next dose taken on the usual day. Your prescriber’s instructions come first.

From section 2 (missed doses) and section 10 (overdose) of the Zepbound and Mounjaro prescribing information, and Zepbound’s Medication Guide, all revised August 2026 and read November 18, 2026. The last column is simple-halving math from the labels’ half-life. On compounded tirzepatide, your prescription sets your schedule, and your prescriber’s instructions come first.
IfWhat the labels sayIn half-life terms
Your dose is up to 4 days late96 hoursThe missed dose is taken as soon as possible; then the usual weekly day resumesThe next dose is still at least 3 days away, the shortest gap the labels allow
It’s more than 4 days lateThe missed dose is skipped, and the next one is taken on the regular dayTaking it then would put two doses less than 3 days apart
You want a new dose dayThe day can change if the two doses are at least 3 days (72 hours) apart3 days after a dose, about 66% to 71% of it is still there
You’ve missed several weeksThe rule is for a missed dose; Zepbound’s label sets no restart dose for a longer break, so your prescriber decidesAfter 4 weeks off, about 2% to 4% of your last steady level is left
You took too muchThe labels point to the Poison Help line, 1-800-222-1222, or a medical toxicologistObservation may need to last a while, the labels say, given the half-life of about 5 days

Swipe the table sideways to see every column.

From section 2 (missed doses) and section 10 (overdose) of the Zepbound and Mounjaro prescribing information, and Zepbound’s Medication Guide, all revised August 2026 and read November 18, 2026. The last column is simple-halving math from the labels’ half-life. On compounded tirzepatide, your prescription sets your schedule, and your prescriber’s instructions come first.

Why 4 days? The labels don’t give a reason, but the numbers fit: a dose taken up to 4 days late still leaves at least 3 days before the next one, the shortest gap the labels allow. With a half-life of 5 to 6 days, doses closer than that would overlap more.

On compounded tirzepatide? There’s no FDA label for it. Your prescription sets your schedule; if it says something different from the labels, your prescriber’s instructions come first. Unsure? Call or text us 24/7 at (949) 818-8000.

More: restarting tirzepatide after a break and what to do if you took too much tirzepatide. Traveling with your vials? Flying with tirzepatide.

Surgery

Should you stop tirzepatide before surgery or a procedure?

Don’t stop tirzepatide for surgery on your own. Tell everyone treating you that you take it: the labels note rare reports of stomach contents getting into the lungs under anesthesia, and multisociety guidance from October 2024 says most people can keep taking GLP-1 medicines. Your care team decides.

From the Zepbound and Mounjaro prescribing information (section 5.9, revised August 2026), the American Society of Anesthesiologists’ statement of June 29, 2023, the multisociety guidance in Clinical Gastroenterology and Hepatology (published October 29, 2024) and the SPAQI consensus abstract (British Journal of Anaesthesia, 2025), all read November 18, 2026. None of these is specific to compounded tirzepatide.
SourceWhat it saysGood to know
The Zepbound and Mounjaro labelssection 5.9, revised August 2026Rare reports of pulmonary aspiration, stomach contents getting into the lungs, in people on GLP-1 medicines under general anesthesia or deep sedation, despite fasting. Patients should tell their providers before any planned surgery or procedure.The data can’t yet show whether changing fasting or briefly stopping the medicine lowers the risk, the labels say
American Society of AnesthesiologistsJune 29, 2023Suggested considering holding a weekly GLP-1 for a week before an elective procedure, and considering a delay if there are stomach symptoms on the dayIn October 2024, the ASA affirmed the newer multisociety guidance below
Multisociety guidanceAGA, ASA, ASMBS, ISPCOP and SAGES; Oct. 29, 2024Most people can keep taking GLP-1 medicines before surgery. Higher risk includes the dose-escalation phase, higher doses and stomach symptoms; for them, it suggests a liquid diet for at least 24 hours before. If a dose is held, it describes a week for weekly medicinesIt calls “the duration to hold therapy” unknown, and warns that holding has its own risks, such as high blood sugar
SPAQI consensus statementBritish Journal of Anaesthesia, 2025Updated recommendations on managing GLP-1 medicines and on fasting times for solids and liquids before anesthesia, from a systematic review and a modified Delphi processIts abstract notes that recent multisociety statements disagree on these questions

Swipe the table sideways to see every column.

From the Zepbound and Mounjaro prescribing information (section 5.9, revised August 2026), the American Society of Anesthesiologists’ statement of June 29, 2023, the multisociety guidance in Clinical Gastroenterology and Hepatology (published October 29, 2024) and the SPAQI consensus abstract (British Journal of Anaesthesia, 2025), all read November 18, 2026. None of these is specific to compounded tirzepatide.

Where the half-life comes in. One held weekly dose lowers tirzepatide but doesn’t clear it: by simple halving, about 38% to 45% of the level after your last shot is still there 7 days later. The labels say the data can’t yet show whether a pause lowers the risk.

Tell them the details. Give your surgeon and anesthesia team your dose, your dose day, the date of your last shot and any nausea, vomiting or bloating. Don’t stop, skip or move a dose for surgery on your own: they and your prescriber decide together.

Have diabetes? The multisociety guidance warns that holding a GLP-1 medicine can raise blood sugar. Ask your diabetes care team how they’ll manage it around surgery.

After surgery, restart when your care team says: restarting tirzepatide after a break.

Birth control and pregnancy

What does tirzepatide’s half-life mean for birth control and pregnancy?

For birth control pills, the issue is tirzepatide’s effect on your stomach: both labels advise a non-oral or barrier backup for 4 weeks after starting and after each dose increase. For pregnancy, Zepbound’s label sets no stop time before you try and advises stopping once a pregnancy is recognized.

“may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying”

Eli Lilly and Company, Zepbound and Mounjaro prescribing information, section 8.3, revised August 2026
Birth control and pregnancy on tirzepatide: what the Zepbound, Mounjaro and Wegovy labels say
Birth control pillsBoth labels advise switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. Non-oral hormonal methods shouldn’t be affected, they say.
Why 4 weeksThe stomach-slowing effect is largest after the first dose and diminishes over time. In a label study, one 5 mg dose cut peak levels of a combined pill’s hormones by 55% to 66% and total exposure by 20% to 23%, with peaks 2.5 to 4.5 hours later.
Planning a pregnancyZepbound’s label sets no stop time before you try, and the half-life math on this page isn’t a waiting time for conceiving. Your prescriber decides your timing.
Once you’re pregnantZepbound’s label says weight loss offers no benefit in pregnancy and may cause fetal harm, and advises stopping once a pregnancy is recognized. Mounjaro’s says to use it in pregnancy only if the potential benefit justifies the potential risk to the fetus.
Semaglutide, for comparisonWegovy’s label (revised June 2026) asks to stop it at least 2 months before a planned pregnancy, because of semaglutide’s long half-life of about 1 week.
BreastfeedingIn a single-dose study, tirzepatide in breast milk was undetectable or low; there are no data on effects on a breastfed baby or on milk production, both labels say.

From the Zepbound and Mounjaro prescribing information (sections 7.2, 8.1, 8.2, 8.3 and 12.3, revised August 2026) and the Wegovy prescribing information (revised June 2026), read November 18, 2026. Compounded tirzepatide wasn’t studied in pregnancy.

Pregnant while taking it? Tell your prescriber right away. Zepbound’s label lists a pregnancy exposure registry for people exposed during pregnancy: 1-844-524-0039.

Plan it together. Tell your prescriber early if you’re planning a pregnancy or breastfeeding; they decide what changes and when. More: GLP-1 medicines for women: birth control, pregnancy and PCOS.

Switching

How does switching between semaglutide and tirzepatide work?

Your prescriber sets the day and the dose when you switch between semaglutide and tirzepatide. Each label advises against combining its medicine with another GLP-1, and both linger: semaglutide’s half-life is about 1 week, tirzepatide’s about 5 days.

  1. Keep your current schedule

    Take your current medicine as prescribed until your prescriber confirms the switch, and tell them the date and dose of your last shot.

  2. Don’t take both

    The Zepbound and Wegovy labels each advise against using their medicine with another GLP-1 medicine.

  3. Get your first-dose day

    Semaglutide’s half-life is about 1 week, and Wegovy’s label says it stays in the circulation for about 5 to 7 weeks after a last 2.4 mg or 7.2 mg shot. Your prescriber tells you which day to take your first tirzepatide dose.

  4. Start at the dose you’re prescribed

    Zepbound’s label starts treatment at 2.5 mg once a week for 4 weeks. Your prescriber sets your starting dose and your steps.

  5. Plan your birth control

    Starting tirzepatide counts as a start: the labels’ 4-week backup advice for birth control pills applies, and again after each dose increase.

  6. Going the other way

    Moving from tirzepatide to semaglutide? Tirzepatide’s half-life is about 5 days, so it lingers too. Your prescriber sets the day of your first semaglutide dose.

The six steps above, in order. Your prescriber’s instructions and your medicine’s label come first.

From the Zepbound and Mounjaro prescribing information (revised August 2026) and the Wegovy prescribing information (revised June 2026), read November 18, 2026. More: switching from semaglutide to tirzepatide and switching from Zepbound to compounded tirzepatide.

Dose steps

What are tirzepatide’s dose steps, in mL and units?

The Zepbound and Mounjaro labels both start at 2.5 mg once a week and go up to 15 mg. Doses rise no faster than every 4 weeks, and most stomach side effects came during those rises. The table shows each dose at 25 mg per mL, as an example only.

Example only: each dose on the Zepbound and Mounjaro labels at 25 mg per mL, the strength of Zepbound’s 15 mg multi-dose vial, in mL and in units on a U-100 syringe. Your vial’s label decides.
DoseVolume at 25 mg/mLUnits (U-100)
2.5 mg0.1 mL10 units
5 mg0.2 mL20 units
7.5 mg0.3 mL30 units
10 mg0.4 mL40 units
12.5 mg0.5 mL50 units
15 mg0.6 mL60 units

Example only. The math: mL = your dose in mg ÷ your vial’s strength in mg per mL, and units = mL × 100 on a U-100 syringe. Zepbound’s multi-dose vials hold each dose in 0.6 mL, so only its 15 mg vial is 25 mg per mL; other vials differ, and your vial’s label decides. Your provider sets your dose and when it changes. Drew more than your dose? Here’s what to do if you took too much tirzepatide. Or enter your own vial’s strength in the tirzepatide dosage calculator.

Compounded tirzepatide

Does compounded tirzepatide last as long as Zepbound or Mounjaro?

The labels can’t say how long compounded tirzepatide lasts: their numbers apply to Zepbound and Mounjaro, the FDA-approved brand-name tirzepatide medicines. Compounded tirzepatide is made by a pharmacy, isn’t FDA-approved and isn’t reviewed by the FDA for safety, effectiveness or quality.

From the Zepbound and Mounjaro prescribing information (revised August 2026) and the FDA’s Compounding and the FDA: Questions and Answers, both read November 18, 2026.
Zepbound or MounjaroCompounded tirzepatide
What it isFDA-approved brand-name tirzepatide medicines, made by Eli LillyMade by a pharmacy for your prescription; not FDA-approved
FDA reviewApproved after FDA reviewNot reviewed by the FDA for safety, effectiveness or quality
Half-lifeAbout 5 days (Mounjaro) or 5 to 6 days (Zepbound), on the labelsNot studied; no FDA label
Your doseSet doses from 2.5 mg to 15 mg, in pens or vialsYour prescription; strength in mg per mL varies, so your vial’s label decides
What’s in itListed on the labelYour pharmacy label lists what’s in the vial
A missed doseA 4-day (96-hour) window, on both labelsYour prescription and your prescriber’s instructions

Swipe the table sideways to see every column.

From the Zepbound and Mounjaro prescribing information (revised August 2026) and the FDA’s Compounding and the FDA: Questions and Answers, both read November 18, 2026.

What to go by. Your prescription. Compounded tirzepatide wasn’t studied in the trials behind the labels, so your prescriber’s instructions come first, including for a missed dose.

Read your vial’s label. Its strength in mg per mL decides how many units your dose is: the tirzepatide dosage chart, what’s in compounded tirzepatide and compounded vs. brand-name tirzepatide.

Report a problem. You or your provider can report a side effect to the FDA at 1-800-FDA-1088.

Cost

What does tirzepatide cost in 2026, every way to pay?

From $50 a month on Medicare’s Bridge, if you qualify, to $449–$699 for Zepbound from 7.5 mg at LillyDirect (depending on refill timing) and $499 for Mounjaro. Here’s each route, with prices as NexLife checked them on Nov. 15, 2026.

Prices from LillyDirect, Lilly’s savings card terms, TrumpRx.gov, CMS and Medicare.gov, checked November 15, 2026. Compounded prices from our GLP-1 price index, checked Nov. 15, 2026.
How you payWhat you payGood to know
Insuranceif your plan covers itYour plan’s copayZepbound’s savings card can bring a covered pen to as little as $25 for a 1- to 3-month fill. It ends December 31, 2026 and isn’t for Medicare or Medicaid
Zepbound at LillyDirectKwikPen or vials, self-pay$299 at 2.5 mg, $399 at 5 mg, $449 from 7.5 mgRefill within 45 days, or 7.5 mg and up costs $499 to $699. A month is 28 days
Mounjaro at LillyDirectself-pay$499 a month at every doseApproved for type 2 diabetes
TrumpRx.govZepbound vialsStarting at $299An out-of-pocket price; Lilly fills the order through LillyDirect
Medicare GLP-1 BridgePart D, if you qualify$50 a monthZepbound KwikPen, with prior authorization (approval needed before it’s covered), through December 31, 2027. Not for type 2 diabetes, moderate to severe sleep apnea or fatty liver disease, which Part D may cover instead
Compounded tirzepatide online25 programs that publish a month-to-month price, all in$126 to $599 a month in our price index (median $285)Not FDA-approved. Checked Nov. 15, 2026
NexLife,compounded tirzepatide, not FDA-approved$115 a month on the 12-month plan$129 month to month; the same price at every dose, with no membership fee

Swipe the table sideways to see every column.

Prices from LillyDirect, Lilly’s savings card terms, TrumpRx.gov, CMS and Medicare.gov, checked November 15, 2026. Compounded prices from our GLP-1 price index, checked Nov. 15, 2026.

NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works

The yearly gap. At $449 a month from 7.5 mg, with a refill within 45 days each time (otherwise $499 at 7.5 mg and $699 at 10 to 15 mg), a year of Zepbound from LillyDirect is 13 four-week fills: $5,837. Compounded tirzepatide at NexLife, which isn’t FDA-approved, is $1,380 a year on the 12-month plan, or $1,548 month to month. It isn’t Zepbound, and a licensed provider decides if it’s right for you.

Have type 2 diabetes? NexLife’s providers prescribe compounded tirzepatide for weight loss. It isn’t a treatment for type 2 diabetes and doesn’t replace Mounjaro or your diabetes care.

Paying less elsewhere for compounded tirzepatide? Our Price Match Guarantee† matches your regular monthly price. More: Zepbound’s cost without insurance and who qualifies for the Medicare Bridge.

At NexLife

Your tirzepatide schedule at NexLife: who helps, and what you pay

Care and access, not a promise: your prescriber decides your doses and your schedule. Here’s who helps.

  1. Tell a licensed provider the whole story

    A licensed provider reviews your health history and prescribes only if compounded tirzepatide is right for you: online, following your state’s rules. Include planned surgeries, pregnancy plans and any birth control pills.

  2. Call or text, any time

    Reach us at (949) 818-8000. Real people answer 24/7, and physicians answer medical questions during clinical hours. Our medical director, Adam Kennah, MD, is board-certified in emergency medicine by the American Board of Emergency Medicine. For an emergency, call 911.

  3. A provider who follows your dose

    If side effects make a dose step hard, your provider decides whether to hold it or lower your dose. Your price stays the same either way.

  4. Help with food

    Every plan includes a nutrition plan and a 1:1 coaching call.

  5. We handle the pharmacy

    A state-licensed 503A partner pharmacy fills your prescription: Absolute Pharmacy in Lutz, FL, or Boudreaux’s New Drug Store in Lake Charles, LA. Questions about your order come to us, and shipping is free and expedited.

  6. One price at every dose

    $115 a month on the 12-month plan, $119 on 6 months, $125 on 3 months or $129 month to month, with no membership fee. Pay with an HSA or FSA card (we provide a letter of medical necessity) or Affirm, Klarna or Afterpay. Not prescribed? No charge for medication. Compounded tirzepatide isn’t FDA-approved, isn’t Zepbound or Mounjaro, and a licensed provider prescribes it only when it offers a significant difference for you.

NexLife is LegitScript-certified and rated 4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026).

Loved by our members

Real stories from NexLife members about their care and service.

A selection of 5-star reviews from Trustpilot, quoted in full as written. Results vary from person to person, and weight loss isn’t guaranteed.

★★★★★TrustScore 4.8 out of 5 on Trustpilot407 reviews as of Nov. 15, 2026 · Read them all ↗

  • ★★★★★Read on Trustpilot ↗

    “That’s a real site with good prices and plans!”

    Estefany L.

  • ★★★★★Read on Trustpilot ↗

    “Affordable, quick and easy. They could not have made it a smoother less stressful experience.”

    Andisheh K.

  • ★★★★★Read on Trustpilot ↗

    “Great communication. Easy to work with. They work to set you up for success.”

    Anthony C.

  • ★★★★★Read on Trustpilot ↗

    “Fast delivery and easy to get a hold of when needing to talk with someone!”

    Browneyes

  • ★★★★★Read on Trustpilot ↗

    “So happy with NexLife. Communication has been great, I’m recommending them to all my friends.”

    April

  • ★★★★★Read on Trustpilot ↗

    “Excellent visit. Dr. Kennah was very knowledgeable and helpful and answered all my questions.”

    Ethan B.

  • ★★★★★Read on Trustpilot ↗

    “Easy and pricing not bad! Customer service was helpful in answering my questions.”

    Lyndy T.

  • ★★★★★Read on Trustpilot ↗

    “Good experience, great team”

    Mai S.

  • ★★★★★Read on Trustpilot ↗

    “Great communciation and was fast and reliable”

    Kiki

  • ★★★★★Read on Trustpilot ↗

    “Very happy so far”

    Tammy E.

  • ★★★★★Read on Trustpilot ↗

    “Fast service great communication!! Willing to work with you!”

    Bon

  • ★★★★★Read on Trustpilot ↗

    “Great service and excellent communication!”

    Gabrielle D.

Names are shortened for privacy. Reviews are members’ opinions, not medical advice.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $115/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan, $1,380 paid upfront; $129/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $95/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan, $1,140 paid upfront; $109/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

TrustScore 4.8 out of 5 on Trustpilot 407 reviews as of Nov. 15, 2026 · Read them all ↗

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

Tirzepatide half-life: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

What is the half-life of tirzepatide?

About 5 days. Mounjaro’s label gives about 5 days, and Zepbound’s gives 5 to 6 days in people with overweight or obesity (both revised August 2026). Half of a dose is cleared in that time, which is why tirzepatide is a once-weekly shot. Compounded tirzepatide wasn’t studied.

How long does tirzepatide stay in your system?

For several weeks after the last dose. The labels give no clearance time, but at a half-life of 5 to 6 days, simple halving leaves about 3% after 5 half-lives: roughly 25 to 30 days. For comparison, Wegovy’s label says semaglutide, with a half-life of about 1 week, stays in the circulation for about 5 to 7 weeks.

How long does Zepbound stay in your system?

Zepbound’s active ingredient is tirzepatide, and its label (revised August 2026) gives a half-life of 5 to 6 days in people with overweight or obesity. By simple halving, about 3% is left after 5 half-lives, 25 to 30 days after the last shot. Your own timing can differ: in a 2022 study of one 5 mg dose, half-lives in the 13 adults with normal liver function ranged from 101 to 158 hours.

When does tirzepatide reach a steady level?

After 4 weeks of once-weekly doses, the Zepbound and Mounjaro labels say (revised August 2026). With a half-life of 5 to 6 days, about 38% to 45% of each dose is still there when the next is due, so levels build for about 4 weeks. Zepbound’s label raises the dose no sooner than every 4 weeks.

When does tirzepatide peak after a shot?

About a day later. Zepbound’s label (revised August 2026) gives a median of 24 hours to peak blood levels, with a range of 8 to 72 hours, and says 80% of a dose reaches the blood. Levels then fall by about half every 5 to 6 days.

What happens if you miss a tirzepatide dose?

Both labels (revised August 2026) say a missed dose is taken as soon as possible within 4 days (96 hours). If more than 4 days have passed, they say to skip it and take the next dose on your regular day. Your prescriber’s instructions come first; on compounded tirzepatide, your prescription sets your schedule.

Can you change the day you take tirzepatide?

Yes, the labels say, as long as your two doses are at least 3 days (72 hours) apart. With a half-life of about 5 days, doses closer than that would overlap more. Ask your prescriber before you move your dose day.

Do you need to stop tirzepatide before surgery?

Not on your own. Tell everyone treating you that you take it: the labels (section 5.9, revised August 2026) note rare reports of stomach contents getting into the lungs under anesthesia or deep sedation. Multisociety guidance from October 29, 2024 says most people can keep taking GLP-1 medicines; if a dose is held, it describes a week for weekly medicines and calls the right hold time unknown. A 2025 consensus statement (SPAQI) notes that published recommendations vary. Your care team decides.

How long before trying to get pregnant should you stop tirzepatide?

Zepbound’s label (revised August 2026) sets no stop time before you try; it advises stopping once a pregnancy is recognized, since weight loss offers no benefit in pregnancy and may cause fetal harm. Its half-life is 5 to 6 days. Semaglutide differs: Wegovy’s label asks for at least 2 months. Tell your prescriber your plans first.

Does tirzepatide make birth control pills less effective?

It can. The Zepbound and Mounjaro labels (revised August 2026) say tirzepatide may make oral hormonal contraceptives less effective because it slows stomach emptying. They advise switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. Non-oral hormonal methods shouldn’t be affected.

How long after stopping semaglutide can you start tirzepatide?

Your prescriber decides; the labels set no waiting time. Each label advises against combining its medicine with another GLP-1 medicine, and semaglutide’s half-life is about 1 week: Wegovy’s label says it stays in the circulation for about 5 to 7 weeks after a last 2.4 mg or 7.2 mg shot. Keep taking semaglutide as prescribed until your prescriber confirms the switch.

Does compounded tirzepatide last as long as Zepbound?

The labels can’t say: their half-life applies to Zepbound and Mounjaro, the FDA-approved brand-name tirzepatide medicines. Compounded tirzepatide is made by a pharmacy, isn’t FDA-approved and isn’t reviewed by the FDA for safety, effectiveness or quality. Follow your prescription and your prescriber’s instructions.

Why is tirzepatide taken once a week?

Because it clears slowly. Zepbound’s label says it carries a fatty acid that binds albumin, a blood protein, and prolongs its half-life, and Mounjaro’s says its half-life of about 5 days enables once-weekly dosing (both revised August 2026).

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2).

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Checked every label fact and study against its source on Nov. 18, 2026. Prices come from the sources listed below, each with its date, and our price index, checked Nov. 15, 2026.

  • How we checked. Half-life, steady state, dosing, missed-dose, surgery, birth control and pregnancy facts come from the Zepbound and Mounjaro prescribing information and Zepbound’s Medication Guide (all revised August 2026), and semaglutide’s from the Wegovy label (revised June 2026), read November 18, 2026, as were a 2022 study in Clinical Pharmacokinetics, the ASA’s 2023 statement, the 2024 multisociety guidance and the 2025 SPAQI consensus abstract. Times after a last dose are simple-halving math from the labels’ half-life, marked as estimates. Prices carry the dates listed under Sources. We don’t give a dosing plan: your prescriber decides. Zepbound, Mounjaro, KwikPen and LillyDirect are trademarks of Eli Lilly and Company, and Wegovy of Novo Nordisk. NexLife isn’t affiliated with either company.
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
  • How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves

Paying less elsewhere? We match it.†

Questions about your dose schedule? Real people answer 24/7.

Start with a 3-minute online check. A licensed provider decides if compounded tirzepatide is right for you, and the price is the same at every dose: $115 a month on the 12-month plan, or $129 month to month.

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Zepbound (tirzepatide) prescribing information and Medication Guide, Eli Lilly (both revised August 2026). Read November 18, 2026.
  2. DailyMed: Zepbound (tirzepatide) label (revised August 2026; updated on DailyMed August 28, 2026). Read November 18, 2026.
  3. Mounjaro (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 18, 2026.
  4. DailyMed: Wegovy (semaglutide) prescribing information (revised June 2026). Read November 18, 2026.
  5. Urva S, et al. Effects of hepatic impairment on the pharmacokinetics of the dual GIP and GLP-1 receptor agonist tirzepatide. Clinical Pharmacokinetics 2022;61:1057-1067. Read November 18, 2026.
  6. American Society of Anesthesiologists: consensus-based guidance on preoperative management of patients on GLP-1 receptor agonists (June 29, 2023). Read November 18, 2026.
  7. Kindel TL, et al. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Clinical Gastroenterology and Hepatology (published October 29, 2024). Read November 18, 2026.
  8. American Gastroenterological Association: most patients can continue GLP-1 anti-obesity drugs before surgery (October 29, 2024). Read November 18, 2026.
  9. Oprea AD, et al. Perioperative management of patients taking GLP-1 receptor agonists: SPAQI multidisciplinary consensus statement. British Journal of Anaesthesia 2025;135(1):48-78. Abstract read November 18, 2026.
  10. FDA: Compounding and the FDA: Questions and Answers (content current as of September 16, 2025). Read November 18, 2026.
  11. LillyDirect: Zepbound self-pay prices. Checked November 15, 2026.
  12. LillyDirect: Mounjaro self-pay prices. Checked November 15, 2026.
  13. Eli Lilly: Zepbound savings card terms. Checked November 15, 2026.
  14. TrumpRx.gov: Zepbound vial. Checked November 15, 2026.
  15. CMS: Medicare GLP-1 Bridge. Checked November 15, 2026.
  16. Medicare.gov: Weight loss drugs (the GLP-1 Bridge). Checked November 15, 2026.
  17. NexLife: GLP-1 price index. Compounded prices checked Nov. 15, 2026.
  18. NexLife: pricing, every plan.